FDA recall, , Moderate risk
Philips EPIQ Elite Diagnostic Ultrasound System
The Philips EPIQ Elite Diagnostic Ultrasound System has a software issue that shows the Doppler sample shallower than its actual measurement location.
What happened
Philips Ultrasound, LLC of Bothell, Washington is recalling the Philips EPIQ Elite Diagnostic Ultrasound System, Model 795125, on its own initiative. The company says a software issue can cause the ultrasound system to display the Doppler sample shallower than its actual measurement location. This may lead to inaccurate blood flow velocity measurements and misdiagnosis.
The company began the recall on October 1, 2026, and customers were told by letter. The product was distributed internationally to Switzerland. The FDA classified the recall on November 17, 2026.
What to do
If a code on your device is listed below:
- Check the lot against the recall notice and ask your provider or supplier before you stop using it.
Typical advice for a recalled medical device; the FDA notice gives no product-specific instructions.
Is yours affected?
Match the model number and UDI-DI listed under your product.
A UDI-DI is the device identifier printed with the barcode on the device label.
Philips EPIQ Elite Diagnostic Ultrasound System
- Model
- 795125
- UDI-DI
- 00884838114234
Recall details
- Posted by FDA
- Recall began
- Status
- Open
- Weekly archive
- Listed the week of Nov 16, 2026
- Sold in
Distributed in Switzerland.
- Recalled by
- Philips Ultrasound, LLCBothell, Washington
- Hazard
- Software defect
- Risk
Moderate risk
Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- FDA event number
- 100039
- Recall number
- Z-0470-2027
- Recall type
- Started by the company
- How the company first told customers
- Letter
All recalls from Philips Ultrasound, LLC
Timeline
FDA's Enforcement Report is its public list of recalls; FDA posts a recall by adding it there.
Philips Ultrasound began the recall
FDA posted the recall to its Enforcement Report and rated it Class II (moderate risk)
Added to Recall Canary



